Mereo BioPharma Group plc

8-K Shareholder vote results May 14, 2026 8-K/A Results of operations (earnings release) May 12, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Completed an acquisition or disposition May 12, 2026 8-K Director or officer change Mar 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Results of operations (earnings release) Mar 19, 2026 8-K Delisting notice or listing-rule failure Feb 17, 2026 8-K Regulation FD disclosure; Other events Jan 12, 2026 8-K Regulation FD disclosure; Other events Dec 29, 2025 8-K Results of operations (earnings release) Nov 10, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Other events Jul 10, 2025 8-K Shareholder vote results May 14, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 26, 2025 8-K Results of operations (earnings release) Mar 26, 2025 8-K Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Entered a material agreement; Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Entered a material agreement; Regulation FD disclosure Jun 14, 2024 8-K Regulation FD disclosure; Other events Jun 12, 2024 8-K Shareholder vote results May 23, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Results of operations (earnings release) May 15, 2024 8-K Entered a material agreement Apr 15, 2024 10-K Fiscal year ended 2023-12-31 Mar 27, 2024 8-K Results of operations (earnings release) Mar 27, 2024 8-K Regulation FD disclosure Jan 8, 2024 6-K Dec 18, 2023 6-K Nov 29, 2023 6-K Nov 16, 2023 6-K Oct 23, 2023 6-K Oct 17, 2023 6-K Sep 20, 2023